These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9544741)

  • 21. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.
    Ricci R; Sumara G; Sumara I; Rozenberg I; Kurrer M; Akhmedov A; Hersberger M; Eriksson U; Eberli FR; Becher B; Borén J; Chen M; Cybulsky MI; Moore KJ; Freeman MW; Wagner EF; Matter CM; Lüscher TF
    Science; 2004 Nov; 306(5701):1558-61. PubMed ID: 15567863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
    Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).
    Fazio S; Sanan DA; Lee YL; Ji ZS; Mahley RW; Rall SC
    Arterioscler Thromb; 1994 Nov; 14(11):1873-9. PubMed ID: 7947615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta.
    Nakata A; Nakagawa Y; Nishida M; Nozaki S; Miyagawa J; Nakagawa T; Tamura R; Matsumoto K; Kameda-Takemura K; Yamashita S; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1333-9. PubMed ID: 10323787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apo E structure determines VLDL clearance and atherosclerosis risk in mice.
    Knouff C; Hinsdale ME; Mezdour H; Altenburg MK; Watanabe M; Quarfordt SH; Sullivan PM; Maeda N
    J Clin Invest; 1999 Jun; 103(11):1579-86. PubMed ID: 10359567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure.
    Groot PH; van Vlijmen BJ; Benson GM; Hofker MH; Schiffelers R; Vidgeon-Hart M; Havekes LM
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):926-33. PubMed ID: 8696955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content.
    Rong JX; Li J; Reis ED; Choudhury RP; Dansky HM; Elmalem VI; Fallon JT; Breslow JL; Fisher EA
    Circulation; 2001 Nov; 104(20):2447-52. PubMed ID: 11705823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.
    Murphy N; Bruckdorfer KR; Grimsditch DC; Overend P; Vidgeon-Hart M; Groot PH; Benson GM; Graham A
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1615-20. PubMed ID: 12842836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.
    van den Maagdenberg AM; Hofker MH; Krimpenfort PJ; de Bruijn I; van Vlijmen B; van der Boom H; Havekes LM; Frants RR
    J Biol Chem; 1993 May; 268(14):10540-5. PubMed ID: 7683682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE*3-Leiden transgenic mice.
    Volger OL; Mensink RP; Plat J; Hornstra G; Havekes LM; Princen HM
    Atherosclerosis; 2001 Aug; 157(2):375-81. PubMed ID: 11472737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.
    van Vlijmen BJ; Gerritsen G; Franken AL; Boesten LS; Kockx MM; Gijbels MJ; Vierboom MP; van Eck M; van De Water B; van Berkel TJ; Havekes LM
    Circ Res; 2001 Apr; 88(8):780-6. PubMed ID: 11325869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
    Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.
    Boesten LS; Zadelaar AS; van Nieuwkoop A; Gijbels MJ; de Winther MP; Havekes LM; van Vlijmen BJ
    Cardiovasc Res; 2005 Apr; 66(1):179-85. PubMed ID: 15769461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.
    Lardenoye JH; Delsing DJ; de Vries MR; Deckers MM; Princen HM; Havekes LM; van Hinsbergh VW; van Bockel JH; Quax PH
    Circ Res; 2000 Aug; 87(3):248-53. PubMed ID: 10926877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.
    Clinton SK; Underwood R; Hayes L; Sherman ML; Kufe DW; Libby P
    Am J Pathol; 1992 Feb; 140(2):301-16. PubMed ID: 1739124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
    Rezaee F; Gijbels M; Offerman E; Verheijen J
    Thromb Haemost; 2003 Oct; 90(4):710-6. PubMed ID: 14515193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions.
    Minami M; Kume N; Shimaoka T; Kataoka H; Hayashida K; Akiyama Y; Nagata I; Ando K; Nobuyoshi M; Hanyuu M; Komeda M; Yonehara S; Kita T
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1796-800. PubMed ID: 11701468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
    Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
    J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.